Diagnosis and treatment of atrophic vaginitis

American Family Physician

Volumn 61, Issue 10, 2000, Pages 3090-3096

  Bachmann, Gloria A ^a   Nevadunsky, Nicole S ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CONJUGATED ESTROGEN; DANAZOL; ESTRADIOL; LEUPRORELIN; LUBRICATING AGENT; MEDROXYPROGESTERONE ACETATE; NAFARELIN ACETATE; TAMOXIFEN CITRATE;

AGING; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; ESTROGEN THERAPY; FEMALE; HUMAN; REVIEW; SEXUAL BEHAVIOR; VAGINA DISEASE; VAGINITIS;

ATROPHY; COITUS; DIAGNOSIS, DIFFERENTIAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE; VAGINA; VAGINITIS;

EID: 0034658676     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Greendale GA, Judd HL. The menopause: health implications and clinical management. J Am Geriatr Soc 1993;41:426-36.
2. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722-7.
3. Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997; 314:228-31.
4. Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982;248:445-8.
5. Rigg LA. Estrogen replacement therapy for atrophic vaginitis. Int J Fertil 1986;31:29-34.
6. Beard MK. Atrophic vaginitis. Can it be prevented as well as treated? Postgrad Med 1992;91:257-60.
7. Kalogeraki A, Tamiolakis D, Relakis K, Karvelas K, Froudarakis G, Hassan E, et al. Cigarette smoking and vaginal atrophy in postmenopausal women. In Vivo 1996;10:597-600.
8. Dupont A, Dupont P, Cusan L, Tremblay M, Rioux J, Cloutier D, et al. Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women. Maturitas 1991;13:297-311.
9. Leiblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L. Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA 1983;249:2195-8.
10. Bachmann GA. Urogenital aging: an old problem newly recognized. Maturitas 1995;22(suppl):S1-5.
11. Mettler L, Olsen PG. Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets. Maturitas 1991;14:23-31.
12. Beard MK, Curtis LR. Libido, menopause, and estrogen replacement therapy. Postgrad Med 1989;86:225-8.
13. Osmers R, Volksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma? Lancet 1990;335:1569-71.
14. Botsis D, Kassanos D, Antoniou G, Vitoratos N, Zourlas PA. Transvaginal sonography in postmenopausal women treated with low-dose estrogens locally administered. Maturitas 1996;23: 41-5.
15. Lupulescu A. Estrogen use and cancer incidence: a review. Cancer Invest 1995;13:287-95.
16. Smith RN, Studd JW. Recent advances in hormone replacement therapy. Br J Hosp Med 1993;49:799-808.
17. Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol 1994; 84:215-8.
18. Smith P, Heimer G, Lindskog M, Ulmsten U. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 1993; 16:145-54.
19. Nachtigall LE. Estrogen replacement: which postmenopausal women benefit? Female Patient 1987; 12:72-86.